Eukaryotic Transcriptome Sequencing (Incl. lncRNA) in UAE | 4500 AED | DHA Licensed

Executive Summary & Core Metrics

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain & VIP Mobile Phlebotomy
Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by DHA‑licensed experts
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731

Test Overview & Methodology

Eukaryotic Transcriptome Sequencing with lncRNA analysis captures the full spectrum of RNA transcripts, enabling detection of gene fusions, expression aberrations, and epigenetic regulators. This advanced NGS‑based test is essential for precision oncology and anti‑aging research, delivering clinically actionable data within 5 weeks. The proprietary bioinformatics pipeline enriches for long non‑coding RNA species that standard RNA‑Seq workflows systematically miss.

Why Choose Our Test

Feature	Our Test	Closest Alternative
Precision	>99% lncRNA detection, full‑length transcript coverage	~85% sensitivity, lncRNAs entirely missed
Method	RNA‑Seq with lncRNA enrichment & proprietary bioinformatics	Standard RNA‑Seq without lncRNA pipeline
Speed	5 weeks (complete report)	3‑4 weeks (gaps in regulatory RNA)
Regulatory Compliance	UAE MOHAP, DHA, & ISO 9001:2015	Limited or none

Physician Insight & Safety Protocols

Physician's Clinical Guidance

“Your transcriptome sequencing results reveal a detailed molecular portrait that must be interpreted within your complete clinical history. Our genomic counselors will walk you through every finding so you fully understand what the data means for your health trajectory. Remember, this advanced test is designed to complement—not replace—the ongoing care provided by your specialist physician.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403)

Important Safety Notice & Medication Warning

Do not discontinue any prescribed medication without consulting your treating physician.
Exclusion Criteria: Not suitable for individuals with active infections, recent blood transfusions (within 4 weeks), or unstable medical conditions. This test is not intended for acute emergency diagnosis.
ER Red Flags: Seek immediate emergency care if you experience new chest pain, severe shortness of breath, sudden confusion, or uncontrolled bleeding. Transcriptome results do not replace urgent clinical evaluation.

This test is performed in compliance with UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability. Personal data is protected under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Patient FAQ & Clinical Guidance

Q: What is eukaryotic transcriptome sequencing including lncRNA?

Eukaryotic transcriptome sequencing with lncRNA profiles all RNA molecules, revealing gene expression patterns and regulatory non‑coding RNAs. This NGS‑based test provides a comprehensive view of both coding and long non‑coding RNA species, which play crucial roles in cancer biology, aging, and cellular regulation. It is used by oncologists to identify actionable mutations and by anti‑aging specialists to uncover novel biomarkers.

Q: Who should consider this test?

Oncology patients, individuals seeking anti‑aging biomarkers, and researchers needing deep transcriptomic insights should consider this test. It is especially valuable for cancer patients requiring comprehensive molecular profiling, healthy adults interested in proactive longevity planning, and biomedical researchers exploring gene regulation. Always discuss with your specialist to determine if transcriptome sequencing fits your clinical or personal health goals.

Q: How long does it take and how to prepare?

Results are ready in 5 weeks; fasting is not required, but avoid recent blood transfusions. For sample collection, a small volume of whole blood is drawn by our VIP phlebotomist at your home; no special preparation is needed besides informing the team of any recent transfusions or active infections. Our cold‑chain logistics ensure sample stability until processing.

Clinical & Logistical Metadata

DHA Facility License	1143
Physical Address	Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Laboratory Brand	DNA Labs UAE
ICD‑10 Code	Z01.89
LOINC Code	98041-5
Price	4,500 AED
Turnaround Time	5 weeks
Accreditation	ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)

ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 1143 | Support & WhatsApp: +971 54 548 8731

This test is conducted in full compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability, Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical interpretations are telephonically supported by DHA‑licensed professionals.

دعم ثنائي اللغة متاح